Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Change Control Request Evaluation and Implementation – V 2.0

Posted on By

API Manufacturing: SOP for Change Control Request Evaluation and Implementation – V 2.0

Standard Operating Procedure for Change Control Request Evaluation and Implementation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/164/2025
Supersedes SOP/API/164/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a systematic and controlled procedure for initiating, reviewing, evaluating, approving, implementing, and closing change control requests (CCRs) in API manufacturing, ensuring GMP compliance, traceability, and product quality assurance.

2. Scope

This SOP is applicable to all proposed changes that may directly or indirectly affect manufacturing processes, facilities, utilities, documentation, equipment, raw materials, packaging materials, testing

methods, and computerized systems within the API manufacturing plant.

3. Responsibilities

  • Change Initiator: Raise the Change Control Request Form with appropriate justification.
  • Department Head: Review technical feasibility and operational impact.
  • QA Head: Evaluate regulatory and quality impact; coordinate change control system.
  • Change Control Committee: Approve or reject changes and oversee implementation.

4. Accountability

The Head of Quality Assurance is accountable for the administration of the change control system, final approval of change controls, and verification of implementation effectiveness.

See also  API Manufacturing: SOP for Emergency Evacuation Procedure in API Plant - V 2.0

5. Procedure

5.1 Types of Change

  • Major Change: Likely to affect product quality or regulatory filings (e.g., formulation changes, new equipment).
  • Minor Change: Limited impact, requires internal documentation (e.g., label text correction).
  • Temporary Change: Time-bound or one-time deviation from a standard process (requires justification and timeline).

5.2 Initiation of Change

  1. The concerned department shall fill out a Change Control Request Form (Annexure-1).
  2. The form shall include:
    • Details of proposed change
    • Justification and rationale
    • Classification (Major/Minor/Temporary)
    • Expected implementation date
  3. Submit the form to QA for registration and evaluation.

5.3 Change Control Register

  1. QA assigns a unique CCR number (e.g., CCR/2025/017).
  2. Enter all details in the Change Control Register (Annexure-2).

5.4 Evaluation and Impact Assessment

  1. The QA team shall assess:
    • Impact on validated systems
    • Impact on regulatory filings
    • Need for requalification or revalidation
    • Training and documentation updates
  2. Departmental review shall include:
    • Engineering – Facility or utility modifications
    • QC – Analytical method or equipment impact
    • Production – Impact on process flow or batch yield
  3. Complete the Impact Assessment Sheet (Annexure-3).

5.5 Review by Change Control Committee

  1. The QA Head shall convene a Change Control Committee (CCC) meeting for review.
  2. CCC shall include representatives from QA, QC, Production, Engineering, Regulatory Affairs, and Warehouse.
  3. The committee decides:
    • Approval
    • Rejection with reasons
    • Modification before re-submission
See also  API Manufacturing: SOP for Issuance of Controlled Copies of SOPs - V 2.0

5.6 Implementation

  1. Upon approval, implementation shall be done as per approved action plan.
  2. QA shall oversee:
    • Equipment requalification
    • Document revision and issuance
    • Process revalidation (if needed)
    • Training to concerned staff
  3. Document implementation evidence in the Change Control Implementation Log (Annexure-4).

5.7 Effectiveness Verification and Closure

  1. After implementation, QA performs effectiveness verification to confirm:
    • No adverse impact on product/process
    • Change is working as intended
  2. QA Head signs the Change Control Closure Form (Annexure-5).
  3. Mark CCR as “Closed” in the Change Control Register.

5.8 Deviation or CAPA Linkage

  1. If a change arises from a deviation, link the CCR number with the deviation or CAPA number for traceability.
  2. Ensure CAPA closure before final CCR closure.

5.9 Archiving and Review

  1. All CCR documentation shall be archived for a minimum of 5 years.
  2. QA shall trend all changes and present analysis in quarterly Quality Review Meetings.

6. Abbreviations

  • CCR: Change Control Request
  • QA: Quality Assurance
  • QC: Quality Control
  • CCC: Change Control Committee
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Change Control Request Form (Annexure-1)
  2. Change Control Register (Annexure-2)
  3. Impact Assessment Sheet (Annexure-3)
  4. Implementation Log (Annexure-4)
  5. Change Control Closure Form (Annexure-5)
See also  API Manufacturing: SOP for Vacuum Drying Procedure - V 2.0

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – Subpart B: Organization and Personnel
  • EU GMP Guidelines – Chapter 1: Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Change Control Request Form

CCR No. Date Proposed Change Initiator Type
CCR/2025/017 12/04/2025 Replace SS pipeline with PTFE Rajesh Kumar Major

Annexure-2: Change Control Register

CCR No. Date Department Status Closed On
CCR/2025/017 12/04/2025 Production Open —

Annexure-3: Impact Assessment Sheet

CCR No. Area Assessed Impact Assessed By
CCR/2025/017 Equipment Qualification Requalification required Sunita Reddy

Annexure-4: Implementation Log

CCR No. Activity Date Performed By Status
CCR/2025/017 Pipeline Replacement 15/04/2025 Maintenance Team Completed

Annexure-5: Change Control Closure Form

CCR No. Closure Date Effectiveness Verified QA Approval
CCR/2025/017 20/04/2025 Yes QA Head

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP System QA Head
14/04/2025 2.0 Updated annexures and impact evaluation workflow Process Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Freeze-Thaw Stability Studies – V 2.0
Next Post: Elixir Department: SOP for Avoiding Cross-Contamination During Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version